The constrained prescription, interchangeability and substitution of biosimilars
Nat Biotechnol
.
2015 Jul;33(7):688-9.
doi: 10.1038/nbt.3272.
Authors
Paola Minghetti
1
,
Paolo Rocco
1
,
Huub Schellekens
2
Affiliations
1
Department of Pharmaceutical Sciences, Università degli Studi di Milano, Milan, Italy.
2
Department of Pharmaceutical Sciences and Department of Innovation Studies, Utrecht University, Utrecht, the Netherlands.
PMID:
26154003
DOI:
10.1038/nbt.3272
No abstract available
Publication types
Letter
MeSH terms
Biosimilar Pharmaceuticals*
Drug Industry
Drug Prescriptions*
Drug Substitution*
Europe
Humans
United States
United States Food and Drug Administration
Substances
Biosimilar Pharmaceuticals